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INTRODUCTION
Sepsis occurs most frequently during the neonatal period,
and is associated with a poor prognosis despite continuous
improvements in intensive care medicine and antibiotic ther-
apy (1, 2). The causes of poor prognosis during sepsis might
be attributable to multiple organ dysfunction syndrome, in-
cluding septic shock, disseminated intravascular coagulation
(DIC), and acute respiratory distress syndrome, caused by acti-
vation of acute inflammatory responses in response to systemic
infection (3).
Although nitric oxide (NO) has been implicated to play a
key role in mediating the acute pathophysiological processes
during sepsis (4), the use of NO synthase (NOS) inhibitors
in sepsis has yielded both beneficial and detrimental effects.
Treatment with NOS inhibitor increased blood pressure and
systemic vascular response (5-9), protected against DIC (10),
and improved survival rate (9) in both animal and clinical stud-
ies of sepsis. However, detrimental hemodynamic effects (11-
14), increased mortality (15-18), and aggravation of DIC (19)
have also been reported with NOS inhibition in both neonatal
and adult models of experimental sepsis. Therefore, the avail-
able data on the role of NO and the efficacy of NOS inhibitors
as a novel adjuvant therapy in sepsis are still controversial, and
further study will be necessary to clarify this.
This study was done to evaluate the role of NO and the effi-
cacy of NOS inhibitors as a novel adjuvant therapy in neonatal
sepsis. We tested the hypothesis that nonselective inhibition
of NOS with N
w-nitro-L-arginine methyl ester (L-NAME) is
detrimental during the early phase of experimental sepsis in
the newborn piglet. In the present study, we used the newborn
piglet as an animal model of neonatal sepsis because the piglet
is comparable in growth spurt, energy metabolism, and vas-
cular anatomy to human newborns at birth (20, 21). It is also
suitable in size for continuous hemodynamic monitoring dur-
ing the experiment. Escherichia coli was used to induce sepsis
because it is the most common Gram-negative pathogen of
neonatal sepsis (1, 2).
MATERIALS AND METHOES
Animal Preparation
The experimental protocols described herein were reviewed
and approved by the Institutional Animal Care and Use Com-
mittee of the Samsung Biomedical Research Center, Seoul,
Korea. This study also followed the institutional and National
Institutes of Health guidelines for laboratory animal care.
Newborn piglets less than 3 days old were anesthetized
with sodium thiopental (5 mg/kg intravenously), paralyzed
with pancuronium (1 mg/kg intravenously), tracheotoimzed,
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Detrimental Effects of N
w-nitro-L-arginine Methyl Ester (L-NAME) in
Experimental Escherichia coli Sepsis in the Newborn Piglet
The role of nitric oxide during neonatal sepsis is complex. We tested the hypothesis
that nonselective inhibition of nitric oxide synthase with N
w-nitro-L-arginine methyl
ester (L-NAME) is detrimental during the early phase of experimental sepsis in the
newborn piglet. Newborn piglets were divided into four groups: 6 in the control
group, 6 in the L-NAME control group, 12 in the sepsis group (SG), and 11 in the
sepsis with L-NAME group (NS). Sepsis was induced by intravenous injection of
10
8 colony forming units of Escherichia coli. L-NAME 10 mg/kg was given intra-
venously 60 min before the induction of sepsis. The survival rate of piglets after
4 hr was 27% in NS, while it was 100% in other groups. Systemic hypotension,
observed in both SG and NS, were more profound in NS. Leukopenia was observed
in both SG and NS. Thrombocytopenia, prolongation of prothrombin time and acti-
vated partial thromboplastin time, and increase in thrombin-antithrombin complexes
were observed only in NS. Decreased PaO2/FiO2 ratio, arterial pH and base excess,
and increased blood lactate levels observed in both SG and NS, but were more pro-
found in NS. These findings suggest that nonselective inhibition of nitric oxide syn-
thase with L-NAME is detrimental during the early phase of experimental neonatal
sepsis.
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Accepted : 9 June 2003and artificially ventilated with mechanical ventilator (Sechrist
Infant Ventilator, IV-100B, Sechrist Industries Co., Anaheim,
CA, U.S.A.). Femoral arteries and veins were cannulated for
blood pressure monitoring and blood sampling, and for med-
ication and fluid infusion, respectively. Electrocardiogram
(ECG), oxygen saturation, and blood pressure were continu-
ously monitored using Hewlett Packard neonatal monitoring
system (Hewlett Packard Model M1276A, Hewlett Packard
Co., MA, U.S.A.). Throughout the experiment, the piglet was
placed under the servo-controlled warmer (Airshields Inc.,
Hatboro, PA, U.S.A.) and rectal temperature was maintained
at between 38.0 and 39.0℃.
Experimental Protocol
After surgery and the period of stabilization, 35 newborn
piglets were divided randomly into four groups: 6 in the con-
trol group (CG), 6 in the L-NAME control group (NG), 12
in the sepsis group (SG), and 11 in the sepsis with L-NAME
group (NS). Sepsis was induced by intravenous injection of 108
colony forming units of E. coli in 100  L of saline. L-NAME
10 mg/kg was given intravenously 60 min prior to the induc-
tion of sepsis. Continuous monitoring of ECG, systemic blood
pressure, and oxygen saturation was done during the experi-
ment. Arterial blood gas analyses, concentrations of glucose,
and lactate in the blood were measured at baseline, and at
every 1 hr for 4 hr after bacterial inoculation. Complete blood
count (CBC), prothrombin time (PT), activated partial throm-
boplastin time (aPTT) and thrombin-antithrombin complexes
were measured at baseline and at the end of the experiment.
Arterial blood gases were measured using a blood gas analyzer
(Ciba-Corning Diagnostics Corp., Medfield, MA, U.S.A.)
and the concentrations of glucose and lactate were measured
using an YSI model 2300 dual analyzer (Yellow Springs
Instrument Co., Yellow Springs, OH, U.S.A.).
Statistical Analysis
Data were analyzed by unpaired t test for inter-group com-
parisons. To detect significant changes over time within each
group, data were compared using repeated measures analysis
of variance with Bonferroni correction. Statistical analysis
described above was done using SAS software program ver.
6.04. A p-value of <0.05 was considered significant. Data were
given as mean±standard deviation.
RESULTS
Survival
All piglets in the SG (n=12), CG (n=6), and NG (n=6)
were found alive at 4 hr after induction of sepsis. In the NS
(n=11), only 3 piglets (27%) were found alive until the end
of the experiment.
Hemodynamic Changes
The CG showed no significant changes in mean arterial pres-
sure (MAP) during the experiment (Fig. 1). In both NG and
NS, MAP increased transiently but significantly, compared
to CG and SG at 1 hr, and returned to baseline values in NG
at 2 hr after L-NAME injection. MAP decreased progressively
in both SG and NS, and became significantly different from
corresponding values in CG and NG after 3 hr. This systemic
hypotension was found more profound in NS.
Physiologic Variables
No significant differences in physiologic values such as heart
rate, arterial pH, PaO2, PaCO2, base excess, and blood lactate
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Fig. 1. Time course of changes in mean arterial pressure in new-
born piglets in each experimental group. ‘CG’ means control group.
‘NG’ means L-NAME control group. ‘SG’ means sepsis group. ‘NS’
means sepsis with L-NAME group. Data are expressed as mean
±standard deviation. 
a: p<0.05 compared to CG, 
b: p<0.05 com-
pared to NG, 
c: p<0.05 compared to SG.
�
a. b.
a, b a, b
a, b, c
b
b
a, c
Heart rate (/min) 201±32 199±47 186±41 235±49
Arterial base excess  0.2±2.0 0.4±2.9 -5.5±3.5
a -22.4±7.5
a,b,c
(mEq/L)
Arterial pH 7.41±0.11 7.35±0.08 7.28±0.14
a6.82±0.26
a,b,c
PaCO2 (mmHg) 41±17 47±12 45±11 66±23
a,b,c
PaO2/FiO2 ratio 260±33 238±37 210±74 139±62
a,b,c
Blood lactate  1.4±0.6 1.0±0.4 2.9±5.2 9.5±6.1
a,b,c
(mmol/L)
CG
(n=6)
NG
(n=6)
SG
(n=12)
NS
(n=11)
Table 1. Physiological data at 4 hr of experiment in each group
of newborn piglets
CG: Control group, NG: L-NAME control group, SG: Sepsis group, NS:
Sepsis with L-NAME group.Values given present mean±standard devia-
tion.
a:p<0.05 compared to CG, 
b:p<0.05 compared to NG, 
c:p<0.05
compared to SG.L-NAME in Neonatal Sepsis 639
levels were observed in CG and NG throughout the experi-
ment (Table 1). Arterial pH and base excess were significantly
reduced in both SG and NS, and these abnormalities were
more profound in NS. Increased PaCO2 and blood lactate lev-
els, and decreased PaO2/FiO2 ratio were observed only in NS.
Hematologic Data 
In both CG and NG, no significant abnormalities in hema-
tologic values were observed during the experiment (Table 2).
Leukopenia was observed in both SG and NS until the end
of experiment. Thrombocytopenia, prolongation of PT and
aPTT, and increase in thrombin-antithrombin complexes were
observed only in NS.
DISCUSSION
The role of NO during sepsis is generally assessed by the
effect of NOS inhibitors (5-19). In the present study, pretreat-
ment with L-NAME increased mortality, aggravated systemic
hypotension, leukopenia, and induced disseminated intravas-
cular coagulation during the early phase of experimental E. coli
sepsis in the newborn piglet. These findings suggest that NO
plays a protective role by attenuating the sepsis-induced mul-
tiple organ dysfunction syndrome, caused by acute inflamma-
tory responses, and that inhibition of NOS might therefore be
detrimental at least during the early phase of neonatal sepsis.
The beneficial effects of NOS inhibitors such as improved
survival rate (9), protection against DIC (10) and increase in
blood pressure (5-9), and brain injury observed in other ani-
mal and clinical studies of sepsis have not been observed in
the present study. However, we have also observed the bene-
ficial effects of NOS inhibition in our previous study of experi-
mental neonatal bacterial meningitis (21). Significant atten-
uation of the acute inflammatory responses and prevention
of brain damage were observed with L-NAME pretreatment
during the early phase of experimental E. coli meningitis in
the newborn piglet. These findings implicate that the friend
or foe simple dichotomy could not account for the complex
role of NO in bacterial sepsis and meningitis.
As the animal model, type and dosage of NOS inhibitors,
etiologic pathogen, and stages of the disease were same in our
present study of sepsis and in our previous study of meningitis
(21); the reasons for this discrepancy between these two differ-
ent compartments of infection remain to be explained. NO
can exert both beneficial and deleterious effects in different
tissues and under different conditions. Three isoforms of NOS
have been described: endothelial NOS (eNOS), neuronal NOS,
and inducible or immunological NOS. Among the three iso-
forms of NOS, NO produced by vascular endothelial cells
(eNOS) has been known to have anti-inflammatory effects
such as limiting platelet aggregation (22), leukocyte adherence
to endothelial cells (23), and microvascular permeability (24).
Therefore, blockade of these beneficial effects of NO with NOS
inhibitors would be responsible for the detrimental effects
observed in the present study of experimental neonatal sepsis.
It is also noteworthy in this regard that a number of studies
have demonstrated that the nonselective inhibition of NOS
activity aggravates organ function (11-14, 19) and survival
rate (15-18) in various animal models of sepsis or endotoxemia.
In our previous study of meningitis (21), secondary bacterial
invasion from central nervous system to the bloodstream, which
would result in secondary septicemia, has not been observed
in the meningitis with L-NAME group, and the blood brain
barrier might also be relatively intact during the early phase
of meningitis. Thus, the activation of vascular eNOS might
have been minimal, and the detrimental effects with NOS
inhibition have not been observed during our previous study
of meningitis. Further studies using selective inhibitors of
NOS will be necessary to substantiate this hypothesis.
Our data of transient but significant increase in blood pres-
sure in both NG and NS immediately after L-NAME pretreat-
ment supports the assumption that NO is a potent endoge-
nous vasodilator (4). In this study, however, L-NAME aggra-
vated septic shock and increased mortality. These detrimen-
tal effects might be attributable to pulmonary hypertension
and reduced cardiac output due to severe vasoconstriction with
NOS inhibition (11-14). More profound decrease in arterial
pH and base excess, and the increase in blood lactate level
observed in NS compared to SG suggests compromised micro-
circulatory blood flow and oxygen delivery to the tissues due
to active vasoconstriction with NOS inhibition during neona-
tal sepsis. Taken together, these findings suggest that NO may
White blood cell (/ L) 9,040±1,017 9,980±3,300 2,500±1,570
a,b 1,900±2,820
a,b
Platelet (×1,000/ L) 242±83 302±77 223±91 108±30
a,b,c
PT (sec) 11.5±1.6 11.7±2.1 12.6±2.1 23.4±9.9
a,b,c
aPTT (sec) 10.6±2.1 11.7±2.2 11.5±3.1 39.3±10.5
a,b,c
TAT (ng/mL) 5.7±3.5 2.8±1.2 13.4±10.6 49.5±12.9
a,b,c
Group NG (n=6) CG (n=6) NG (n=6) NS (n=11)
Table 2. Hematologic data of the newborn piglets in each experimental group
CG: Control group, NG: L-NAME control group, SG: Sepsis group, NS: Sepsis with L-NAME group, PT: Prothrombin time, aPTT: activated partial
thromboplastin time, TAT: Thrombin-antithrombin complexes. Values given present mean±standard deviation. 
a: p<0.05 compared to CG, 
b: p<0.05
compared to NG, 
c: p<0.05 compared to SG.640 S.S. Kim, J.H. Hwang, C.W. Choi, et al.
play an important role in maintaining organ blood flow and
tissue oxygenation during the early phase of neonatal sepsis.
Our data of leukopenia, thrombocytopenia, and induction
of DIC in NS suggest that nonspecific inhibition of NOS might
be detrimental by blocking the anti-inflammatory effects of
eNOS (19, 22-24). Besides aggravating pulmonary hyperten-
sion and physiologic shunting (11-14), increased leukocyte
and platelet infiltration into the lung tissue with NOS inhibi-
tion might also contribute to decreased PaO2/FiO2 ratio ob-
served in NS during this study (19).
In summary, inhibition of NOS with L-NAME is detrimen-
tal as evidenced by increasing mortality, aggravating systemic
hypotension, leukopenia, and inducing disseminated intravas-
cular coagulation during the early phase of experimental E. coli
sepsis in the newborn piglet. These findings suggest that some
of the NO produced during neonatal sepsis is beneficial, and
inhibition of NOS as adjuvant therapy must be approached
with great caution.
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